<DOC>
	<DOCNO>NCT00001688</DOCNO>
	<brief_summary>This pilot study evaluate ability highly active antiretroviral therapy administer child HIV-1 infection effect immunoreconstitution child HIV-1 infection . In addition , study determine safety combination therapy ritonavir , nevirapine stavudine ( d4T ) well anti-HIV activity combination therapy ritonavir , nevirapine stavudine . A total 25 HIV-1 infected child study , include moderately severely immunocompromised individual . The child treat ritonavir , nevirapine stavudine predefined drug substitution case intolerance . Immunoreconstitution , define repopulation naive T cell , study determine presence extent production new naive ( thymic derive ) CD4+ T cell T cell receptor repertoire . Drug pharmacokinetic profile regimen examine .</brief_summary>
	<brief_title>A Pilot Study Immunologic Reconstitution HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir , Nevirapine Stavudine</brief_title>
	<detailed_description>This pilot study evaluate ability highly active antiretroviral therapy administer child HIV-1 infection effect immunoreconstitution child HIV-1 infection . In addition , study determine safety combination therapy ritonavir , nevirapine stavudine ( d4T ) well anti-HIV activity combination therapy ritonavir , nevirapine stavudine . A total 25 HIV-1 infected child study , include moderately severely immunocompromised individual . The child treat ritonavir , nevirapine stavudine predefined drug substitution case intolerance . Immunoreconstitution , define repopulation naive T cell , study determine presence extent production new naive ( thymic derive ) CD4+ T cell T cell receptor repertoire . Drug pharmacokinetic profile regimen examine .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<criteria>Children age 4 year 18 year . Diagnosis HIV1 infection define Centers Disease Control ( CDC ) Definition . Availability parent guardian provide Informed Consent . Child critically ill clinically unstable . No CDC category N1 A1 ( 1994 revise classification HIV infection child less 13 year age ) CDC 1993 revise HIV classification expand AIDS surveillance definition adolescent adult . Nonpresence active opportunistic infection require acute intervention time entry ( e.g . CMV , aspergillosis , cryptococcosis , Candida , etc. ) . Patients receive treatment infection require prolonged treatment must stable therapy least 30 day prior study entry . No administration chemotherapeutic agent , investigational agent use immunomodulating agent IVIG , corticosteroid , interferon , pentoxifylline , GCSF/GMCSF , erythropoeitin , growth hormone growth factor within one month enrollment . None follow laboratory abnormality within 2 week study entry : Total WBC count le 1500/mm ( 3 ) absolute neutrophil count le 750/mm ( 3 ) ; Hemoglobin le 8.0 g/dl ; Platelet count le 75,000/mm ( 3 ) ; Creatinine great 2.0 x normal ; Creatinine clearance less equal 50 mL/min/m ( 2 ) ; Total bilirubin great 2 x normal ; SGOT/SGPT great 5 x normal ; Serum amylase pancreatic isoenzyme great 90 U/L ( 2 x upper limit normal adult ) . Serum amylase pancreatic isoenzyme obtain total serum amylase great 180 U/L . No history clinical pancreatitis and/or elevation serum amylase pancreatic isoenzyme great 180 U/L . No history peripheral neuropathy Grade II great severity . No previous treatment ritonavir , indinavir , nelfinavir , nevirapine stavudine . Patients may receive treatment ritonavir , indinavir , nelfinavir less 4 week . Ability swallow tablet . No child volume research blood require study evaluation exceed maximum volume research blood allowable ( 3 ml/kg single blood withdrawal 7 ml/kg 6week period ) . This would applicable child le 16.5 kg . No patient refuse leukapheresis do . Sexually active postmenarchal female must willing use barrier method contraception willing remain sexually abstinent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2001</verification_date>
	<keyword>CD4 Cells</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Anti-Retroviral Activity</keyword>
	<keyword>V Beta Repertoire</keyword>
	<keyword>CD-4-Naive T Cells</keyword>
	<keyword>CD-4-Memory T Cells</keyword>
</DOC>